Treating Caregiver Stress and Health in Bipolar Disorder
治疗双相情感障碍中的照顾者压力和健康
基本信息
- 批准号:7047602
- 负责人:
- 金额:$ 18.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-15 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:behavioral /social science research tagbipolar depressioncaregiversclinical researchclinical trialscognitive behavior therapycopingcost effectivenessfamily structure /dynamicsfocus groupshandbookhealth behaviorhuman subjecthuman therapy evaluationmental health educationquestionnairesself carestress managementtherapy design /developmentvideotape /videodisc
项目摘要
DESCRIPTION (provided by applicant): There is a critical need for psychosocial interventions to help alleviate the stress and stress-related health and mental health problems experienced by family members caring for a relative with bipolar disorder, a recurrent and disabling mental disorder affecting 1% of the population. The proposed research aims to develop and test the first intervention to directly target the self-care deficits and compromised mental and physical health of caregivers of patients with bipolar illness, as well as the high perceived stress, and ineffective coping that help promote them. A Stage 1-3 treatment development study will create, manualize and pilot test a health-promoting intervention (HPI) that combines psychoeducation about caregiving stress and associated health and mental health risks with CBT techniques to identify and modify barriers to caregiver self-care. In Stages 1-2 a team of 3 clinical investigators from 3 research sites will develop the manual, adherence/competence and outcome measures, and run 6 feasibility cases. In Stage 3, 46 primary caregivers (PC's) of patients with SCID-diagnosed Bipolar I or II Disorder will be randomized to receive either the 15-session HPI delivered by the clinical investigators, or up to 4 sessions of a self-administered, videotaped psychoeducational control condition (CC). The efficacy of HPI vs. CC in reducing depression and poor physical health (primary outcomes) and caregiver burden, anxiety, self-care/prevention deficits, ineffective coping, and costs to caregivers (secondary outcomes) will be evaluated using multivariate regression and/or random effects models, in an intent-to-treat design. Training materials will be developed for a larger-scale study.
描述(由申请人提供):迫切需要心理社会干预,以帮助缓解家庭成员照顾双相情感障碍亲属所经历的压力和压力相关的健康和心理健康问题,双相情感障碍是一种影响1%人口的复发性和致残性精神障碍。拟议的研究旨在开发和测试第一种干预措施,以直接针对双相情感障碍患者的照顾者的自我护理缺陷和身心健康受损,以及高感知压力和无效的应对措施。第1-3阶段的治疗开发研究将创建,手动和试点测试健康促进干预(HPI),将有关减轻压力和相关健康和心理健康风险的心理教育与CBT技术相结合,以确定和修改照顾者自我护理的障碍。在第1-2阶段,来自3家研究中心的3名临床研究者组成的团队将制定手册、依从性/能力和结局指标,并运行6个可行性病例。在第3阶段,46名诊断为SCID的双相I型或II型障碍患者的主要照顾者(PC)将随机接受由临床研究者提供的15次HPI,或最多4次自我管理的录像心理教育控制条件(CC)。将在意向治疗设计中,使用多变量回归和/或随机效应模型评价HPI与CC在减轻抑郁和身体健康不良(主要结局)以及护理者负担、焦虑、自我护理/预防缺陷、无效应对和护理者成本(次要结局)方面的疗效。将为更大规模的研究编制培训材料。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah A. Perlick其他文献
Deborah A. Perlick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah A. Perlick', 18)}}的其他基金
Reducing the Adverse Impact of Mental Illness Stigma Among Family Caregivers
减少家庭护理人员精神疾病耻辱的不利影响
- 批准号:
7667402 - 财政年份:2007
- 资助金额:
$ 18.54万 - 项目类别:
Reducing the Adverse Impact of Mental Illness Stigma Among Family Caregivers
减少家庭护理人员精神疾病耻辱的不利影响
- 批准号:
7321286 - 财政年份:2007
- 资助金额:
$ 18.54万 - 项目类别:
Treating Caregiver Stress and Health in Bipolar Disorder
治疗双相情感障碍中的照顾者压力和健康
- 批准号:
7447813 - 财政年份:2006
- 资助金额:
$ 18.54万 - 项目类别:
Treating Caregiver Stress and Health in Bipolar Disorder
治疗双相情感障碍中的照顾者压力和健康
- 批准号:
7285208 - 财政年份:2006
- 资助金额:
$ 18.54万 - 项目类别:
Bipolar Illness Therapy, Family Burden, Costs & Health
双相情感障碍治疗、家庭负担、费用
- 批准号:
6446747 - 财政年份:2001
- 资助金额:
$ 18.54万 - 项目类别:
Bipolar Illness Therapy, Family Burden, Costs & Health
双相情感障碍治疗、家庭负担、费用
- 批准号:
6665167 - 财政年份:2001
- 资助金额:
$ 18.54万 - 项目类别:
Bipolar Illness Therapy, Family Burden, Costs & Health
双相情感障碍治疗、家庭负担、费用
- 批准号:
6528994 - 财政年份:2001
- 资助金额:
$ 18.54万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 18.54万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 18.54万 - 项目类别:
Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 18.54万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 18.54万 - 项目类别:
Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 18.54万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 18.54万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 18.54万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 18.54万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 18.54万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 18.54万 - 项目类别: